Skip to main content
Equibles

Deep Track Capital, LP

Position in GMAB — Genmab A/S

CIK 1856083 GREENWICH, CT
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$155,205,500
+$56,920,503 QoQ
Shares Held
5,650,000
+54.2% QoQ
Ownership
0.919%
of shares outstanding
% of Portfolio
2.36%
of 13F equity value
Holder Rank
#5
of 292 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Derivatives in GMAB

reported options exposure · as of Jun 30, 2026
CallValue
$82,410,000
CallShares
3,000,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. GMAB ranks #15 (2.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IMVT
Immunovant, Inc.
 9,341,151 $359,914,548
2 GPCR
Structure Therapeutics Inc.
 4,740,072 $254,399,664
3 PCVX
Vaxcyte, Inc.
 4,300,000 $249,959,000
4 ALNY
Alnylam Pharmaceuticals, Inc.
 825,000 $248,349,750
5 MANE
Veradermics, Inc
 2,000,000 $245,880,000
6 TARS
Tarsus Pharmaceuticals, Inc.
 3,666,768 $230,786,377
7 OCUL
Ocular Therapeutix, Inc
 19,686,282 $193,319,289
8 BMRN
Biomarin Pharmaceutical Inc
 3,307,481 $189,254,062

All Filings in GMAB

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $82,410,000 3,000,000
2026-06-30 $155,205,500 5,650,000
2026-03-31 $98,284,997 3,663,250
2025-09-30 $14,760,458 481,267
2024-12-31 $41,740,000 2,000,000